All In Biotech

Drug Trial Radar · NCT02065700

Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Participants

A Multicenter, Open-label, Long-term Follow-up Safety and Efficacy Study of GLPG0634 Treatment in Subjects With Moderately to Severely Active Rheumatoid Arthritis

Last checked: Nov 19, 2026Latest source record: Jun 4, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

739

Actual

Start

Feb 25, 2014

Primary completion

Jan 19, 2023

Study completion Jan 19, 2023

Sponsor

Lead sponsor
Lakefront Biotherapeutics NVIndustry
Sponsor type
Industry
Collaborators
Gilead Sciences
First posted
Feb 19, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of the study was to evaluate the long-term safety and tolerability of filgotinib (formerly GLPG0634) for the treatment of rheumatoid arthritis. Participants were enrolled in this open-label long-term follow-up study after they had completed one of the two core studies, GLPG0634-CL-203 (DARWIN1) (NCT01888874) or GLPG0634-CL-204 (DARWIN2) (NCT01894516), and were evaluated for any side effects that might have occured (long-term safety and tolerability) when taking filgotinib. During the course of the study, participants were also examined for long-term effects of filgotinib administration on disease activity (efficacy), participant's disability, fatigue, and quality of life.

Conditions

  • Rheumatoid Arthritis

Interventions

  • FilgotinibDrug

    Administered as Oral Tablets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants Experiencing Treatment-Emergent Adverse EventsTime frame: From First dose to Week 437

Locations

111 sites in 22 countries. Site status is shown where the registry gives one.

  • Arthro, Arthritis Care & Research

    Gilbert, Arizona

  • Arizona Arthritis & Rheumatology Research PLLC

    Mesa, Arizona

  • C.V. Mehta MD Medical Corp.

    Hemet, California

  • Desert Medical Advances

    Palm Desert, California

  • RASF Clinical Research Center

    Boca Raton, Florida

  • Millenium Research

    Ormond Beach, Florida

  • Lovelace Scientific Resources

    Venice, Florida

  • Springfield Clinic

    Springfield, Illinois

  • Klein and Associates MD, PA

    Hagerstown, Maryland

  • Physicians East

    Greenville, North Carolina

  • Health Research of Oklahoma

    Oklahoma City, Oklahoma

  • Low County Rheumatology PA

    Charleston, South Carolina

  • West Tennessee Research Institute

    Jackson, Tennessee

  • Austin Rheumatology Research PA

    Austin, Texas

  • Pioneer Research Solutions Inc

    Houston, Texas

  • Atencion Integral en Reumatologa

    Buenos Aires, Argentina

  • CER Intituto Medico

    Buenos Aires, Argentina

  • Organizacion Medica de Investigaciones (OMI)

    Buenos Aires, Argentina

  • Instituto Reumatologico Strusberg

    Córdoba, Argentina

  • CIMeL Centro dee Investigacion Medico Lanus

    Lanus, Argentina

  • Instituto CAICI

    Rosario, Argentina

  • Instituto de Asistencia Reumatologia Integral - IARI

    San Fernando, Argentina

  • Centro Médico Privado de Reumatologia

    San Miguel de Tucumán, Argentina

  • Princess Alexandra Hospital

    Woolloongabba, Australia

  • Flinders Medical Centre

    Bedford Park, Flinders Drive, South Australia, Australia

  • Monash Medical Centre

    Clayton, Victoria, Australia

  • Cliniques Universitaires St-Luc

    Brussels, Belgium

  • UZ Leuven

    Leuven, Belgium

  • University "Multiprofile Hospital for Active Treatment - Kaspela" LTD

    Plovdiv, Bulgaria

  • Multiprofile Hospital for Active Treatment - Ruse

    Rousse, Bulgaria

  • Diagnostic Consultative Center "Sveta Anna" LTD

    Sofia, Bulgaria

  • National Multiprofile Transport Hospital "Tsar Boris III," Sofia, Clinical of Internal Diseases

    Sofia, Bulgaria

  • University Multiprofile Hospital for Active Treatment "SV. Ivan Rilski" EAD, Sofia, Rheumatology Clinic

    Sofia, Bulgaria

  • Hospital Regional "Guillermo Grant Benavente"

    Santiago, Chile

  • Prosalud

    Santiago, Chile

  • Someal SA

    Santiago, Chile

  • Centro de Investigacion Clinica del Sur

    Temuco, Chile

  • Consulta Privada Dra. Ponce

    Temuco, Chile

  • Circaribe S.A.S

    Barranquilla, Colombia

  • Centro de Investigacion en Reumatologia y Especialidades Medicas (CIREEM)

    Bogotá, Colombia

Showing 40 of 111 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.